The main scientific paper from our first study (SONIA 1) was published last week in the Annals of Rheumatic Diseases. This is a very exciting first step for us in our DevelopAKUre clinical trial! This study was the first part of our ongoing clinical trial, and helped us decide what dose of nitisinone is best for patients. In today’s DevelopAKUre blog Oliver tells us about the results presented in the paper, and explains why they are important: buff.ly/1w52iPb If you have any questions about the paper, comment below, or get in touch with Oliver at [email protected]
Posted on: Mon, 08 Dec 2014 15:00:17 +0000
Trending Topics
Recently Viewed Topics
© 2015